| Call Number (LC) | Title | Results |
|---|---|---|
| RM301.42 .E88 1989 | QSAR : quantitative structure-activity relationships in drug design : proceedings of the 7th European Symposium on QSAR, held in Interlaken, Switzerland, 5-9 September 1988 / | 2 |
| RM301.42 .E88 1990 | QSAR, rational approaches to the design of bioactive compounds : proceedings of the VIII European Symposium on Quantitative Structure-Activity Relationships, Sorrento, Italy, 9-13 September 1990 / | 1 |
| RM301.42 .F384 2011 | Frontiers in Drug Design & Discovery Volume 5. | 1 |
| RM301.42 .F7313 1984 | Theoretical drug design methods / | 1 |
| RM301.42 .K83 1993eb | QSAR Hansch analysis and related approaches / | 1 |
| RM301.42 .M37 2010 | Quantitative drug design : a critical introduction / | 1 |
| RM301.42 .M65 2008eb |
Molecular drug properties measurement and prediction / Molecular drug properties : measurement and prediction / |
2 |
| RM301.42 .N37 1996 | Structure-based drug design : experimental and computational approaches / | 1 |
| RM301.42 .N487 1996eb | Neural networks in QSAR and drug design | 1 |
| RM301.42 .Q28 1995eb | QSAR and drug design new developments and applications / | 1 |
| RM301.42 .Q283 2006eb |
QSAR and molecular modeling studies in heterocyclic drugs. Qsar and molecular modeling studies in heterocyclic drugs I |
2 |
| RM301.42 .Q35 |
Molecular informatics QSAR & combinatorial science |
2 |
| RM301.42 Q35 | Quantitative structure-activity relationships including molecular modelling and applications of computer graphics in pharmacology, chemistry, and biology QSAR. | 1 |
| RM301.42 .Q73 2006 | QSAR and molecular modeling studies in heterocyclic drugs / | 1 |
| RM301.42 .S49 2002 | Drug membrane interactions : analysis, drug distribution, modeling / | 1 |
| RM301.42 .S74 1983 | Stereochemistry and biological activity of drugs / | 1 |
| RM301.45 |
Bioequivalence requirements in various global jurisdictions / FDA bioequivalence standards / |
2 |
| RM301.45 .A796 2015 | Arzneimitteltherapiesicherheit im Spannungsfeld von vollständiger Medikationsübersicht, mündigem Patienten und individualisierter Medikation. | 1 |
| RM301.45 .F33i | FDA orange book approved drug products with therapeutic equivalence evaluation (annual edition). | 1 |
| RM301.45 .F332i | FDA orange book approved drug products with therapeutic equivalence evaluation (monthly cumulative supplement). | 1 |
